Cargando…

Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus

Detalles Bibliográficos
Autores principales:	Rullo, Ornella J, Woo, Jennifer MP, Hoftman, Alice DC, Parsa, Miriam F, Amarilyo, Gil, McCurdy, Deborah K, Tsao, Betty P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403068/ http://dx.doi.org/10.1186/1546-0096-10-S1-A123

Ejemplares similares

Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2013)

Ethnic differences in pediatric SLE early disease severity: a comparison between Hispanic-Americans and European-Americans
por: Liu, Peony, et al.
Publicado: (2012)

Implementation of an electronic interface for the documentation of pediatric rheumatology medical records improves physician and patient utilization of time in clinic
por: Woo, Jennifer MP, et al.
Publicado: (2012)

Role of Osteopontin in Systemic Lupus Erythematosus
por: Kaleta, Beata
Publicado: (2014)

Osteopontin Alleles Are Associated with Clinical Characteristics in Systemic Lupus Erythematosus
por: Trivedi, Tarak, et al.
Publicado: (2011)

Leptin Enhances Availability of Apoptotic Cell-Derived Self-Antigen in Systemic Lupus Erythematosus
por: Amarilyo, Gil, et al.
Publicado: (2014)

Osteopontin - a biomarker for organ damage in paediatric lupus?
por: Briggs, Tracy A
Publicado: (2013)

Osteopontin and Systemic Lupus Erythematosus Association: A Probable Gene-Gender Interaction
por: Han, Shizhong, et al.
Publicado: (2008)

Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series
por: Wong, Stephen C., et al.
Publicado: (2021)

KIR-HLA class I combinations in JIA-associated uveitis
por: Parsa, Miriam, et al.
Publicado: (2012)

The preliminary association study of osteopontin 707 C/T polymorphism with systemic lupus erythematosus in a Polish population
por: Kaleta, Beata, et al.
Publicado: (2020)

Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
por: Woo, Jennifer MP, et al.
Publicado: (2010)

HMGB1 in Systemic Lupus Erythematosus
por: Liu, Tianye, et al.
Publicado: (2020)

A glimpse into the future of systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2022)

Fine mapping and functional study of the systemic lupus erythematosus-associated NMNAT2/SMG7 locus
por: Zhao, Jian, et al.
Publicado: (2014)

Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus
por: Wirestam, Lina, et al.
Publicado: (2021)

DNA repair in lupus
por: Xu, Jiadi, et al.
Publicado: (2014)

Blimp-1 and systemic lupus erythematosus
por: Diamond, Betty, et al.
Publicado: (2014)

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
por: Urowitz, Murray B., et al.
Publicado: (2022)

Follicular Helper T Cells in Systemic Lupus Erythematosus
por: Kim, Sun Jung, et al.
Publicado: (2018)

Serum uric acid is associated with damage in patients with systemic lupus erythematosus
por: Elera-Fitzcarrald, Claudia, et al.
Publicado: (2020)

Inhibition of Aberrant Circulating Tfh Cell Proportions by Corticosteroids in Patients with Systemic Lupus Erythematosus
por: Feng, Xuebing, et al.
Publicado: (2012)

Therapy of systemic lupus erythematosus: a look into the future
por: Smolen, Josef S
Publicado: (2002)

Damage index in childhood-onset systemic lupus erythematosus in Egypt
por: Salah, Samia, et al.
Publicado: (2011)

Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
por: Harden, Olivia C., et al.
Publicado: (2020)

Therapy Side Effects in Systemic Lupus Erythematosus
por: POPA, R., et al.
Publicado: (2018)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Regulatory T cells in systemic lupus erythematosus: past, present and future
por: Horwitz, David A
Publicado: (2008)

Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies
por: Little, Alicia J., et al.
Publicado: (2020)

Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
por: Niebel, Dennis, et al.
Publicado: (2023)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus
por: Malkiel, Susan, et al.
Publicado: (2018)

Cervical Health in Systemic Lupus Erythematosus
por: Dhar, J. Patricia, et al.
Publicado: (2023)

Evaluation of Thrombocytopenia in Systemic Lupus Erythematosus and Correlation with Different Organs Damages
por: Ktona, Ergeta, et al.
Publicado: (2014)

Osteoporosis in Systemic Lupus Erythematosus - Correlations with Disease Activity and Organ Damage
por: BARBULESCU, A., et al.
Publicado: (2015)

Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus
por: Suarez-Fueyo, Abel, et al.
Publicado: (2019)

Placental damage in pregnancies with systemic lupus erythematosus: A narrative review
por: Castellanos Gutierrez, Aleida Susana, et al.
Publicado: (2022)

Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus
por: Jacobi, Annett M., et al.
Publicado: (2005)

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cs3bfu4f8f4cmvfli5ccv2mh3u